Tests finding feasibility of mixing Covid vaccines to start in few weeks, says head of the Covid-19 working group

By: |
May 31, 2021 2:31 PM

The clinical experimentation process will take place under the collaboration of the vaccine makers and the Indian Council of Medical research

covid 19 vaccinesVaccination would be done in government hospitals, primary health centres also at designated centres in all the four regions of Puducherry, Karaikal, Mahe and Yanam.

India will soon start testing the consequences of mixing two different Covid-19 vaccines and study its feasibility if it helps in boosting immunity response, create antibodies to the virus. The scientists will conduct the experiments using the vaccines already available in the market and those in the pipeline reported IE.

According to Dr. N K Arora, chairman of the Covid-19 working group under the National Technical Advisory Group on Immunization (NTAGI). Eight vaccines will be mixed and matched during the testing, three currently DGCI approved vaccines Serum Institute’s Covishield, Bharat Biotech’s Covaxin, and Russian Sputnik V.

The clinical experimentation process will take place under the collaboration of the vaccine makers and the Indian Council of Medical research The tests will try to find out whether the vaccines can be given together, one dose of each, and if so which one should be administered first and which ones go next. The process will also study if a vaccine cocktail can provide more protection against SARS-Cov-2, said Dr. Arora.

Various factors will be taken into account here, like proper research study in actual field conditions to study the mixing of vaccines. The aim is to find if mixing them and to what extent can provide better immunity without any adverse effects, Dr. Arora pointed out. Although both the vaccines individually are safe to be administered the objective now will be to see if they are safe and effective with each other. However, he emphasized the fact that not every vaccine will be able to undergo the mix and max process.

The Covid-19 working group, NTAGI, and National Expert Group on Covid-19 Vaccine Administration (NEGVAC) have proposed the feasibility of mixing vaccines at every level, said Dr. Arora. The trials after mixing the vaccines will be conducting in the country’s existing immunisation program, he added.

At present, there are six Covid vaccines in the pipeline, SII’s Covax, Zyndus Vadila’s ZyCov-D, Biological E’s Corbevax, Bio E’s version of Johnson and Johnson Covid vaccine, Genova’s mRNA vaccine, and Bharat Biotech’s intranasal Covid-19 vaccine. Pfizer is also in talks with the government to bring it to the Indian market this year.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Single dose of Pfizer, AstraZeneca Covid vaccine offers 60 per cent protection: Lancet study
2Australians are cancelling their appointments for second AstraZeneca vaccine dose; here is why
3Here’s how pharma companies can leverage digital to market better